1. Home
  2. OGEN vs MOVE Comparison

OGEN vs MOVE Comparison

Compare OGEN & MOVE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OGEN
  • MOVE
  • Stock Information
  • Founded
  • OGEN 1996
  • MOVE 2018
  • Country
  • OGEN United States
  • MOVE United States
  • Employees
  • OGEN N/A
  • MOVE N/A
  • Industry
  • OGEN Biotechnology: Pharmaceutical Preparations
  • MOVE Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • Sector
  • OGEN Health Care
  • MOVE Health Care
  • Exchange
  • OGEN Nasdaq
  • MOVE Nasdaq
  • Market Cap
  • OGEN 4.6M
  • MOVE 5.3M
  • IPO Year
  • OGEN N/A
  • MOVE 2021
  • Fundamental
  • Price
  • OGEN $4.13
  • MOVE $0.70
  • Analyst Decision
  • OGEN
  • MOVE Buy
  • Analyst Count
  • OGEN 0
  • MOVE 1
  • Target Price
  • OGEN N/A
  • MOVE $30.00
  • AVG Volume (30 Days)
  • OGEN 656.3K
  • MOVE 250.0K
  • Earning Date
  • OGEN 08-08-2025
  • MOVE 08-13-2025
  • Dividend Yield
  • OGEN N/A
  • MOVE N/A
  • EPS Growth
  • OGEN N/A
  • MOVE N/A
  • EPS
  • OGEN N/A
  • MOVE N/A
  • Revenue
  • OGEN N/A
  • MOVE $1,013,000.00
  • Revenue This Year
  • OGEN N/A
  • MOVE $1,460.71
  • Revenue Next Year
  • OGEN N/A
  • MOVE $96.77
  • P/E Ratio
  • OGEN N/A
  • MOVE N/A
  • Revenue Growth
  • OGEN N/A
  • MOVE N/A
  • 52 Week Low
  • OGEN $3.12
  • MOVE $0.51
  • 52 Week High
  • OGEN $75.60
  • MOVE $6.97
  • Technical
  • Relative Strength Index (RSI)
  • OGEN 47.04
  • MOVE 47.73
  • Support Level
  • OGEN $3.41
  • MOVE $0.61
  • Resistance Level
  • OGEN $4.85
  • MOVE $0.85
  • Average True Range (ATR)
  • OGEN 0.58
  • MOVE 0.10
  • MACD
  • OGEN 0.01
  • MOVE 0.02
  • Stochastic Oscillator
  • OGEN 42.49
  • MOVE 43.49

About OGEN Oragenics Inc.

Oragenics Inc is engaged in the research and development of nasal delivery pharmaceutical medications in neurology and fighting infectious diseases. The company's product ONP-002 is a fully synthetic, non-naturally occurring neurosteroid, is lipophilic, and can cross the blood-brain barrier to rapidly reduce swelling, oxidative stress and inflammation while restoring proper blood flow through gene amplification. The Company operates in one reportable segment, which includes activities related to advancing the development of its concussion drug, ONP-002.

About MOVE Movano Inc.

Movano Inc is developing a platform to deliver purpose-driven healthcare solutions to bring medical-grade, high-quality data to the forefront of consumer health devices. its initial commercial product in development is the Evie Ring, a wearable designed specifically for women. The Evie Ring combines health and wellness metrics to give a full picture of one's health, which includes resting heart rate, heart rate variability (HRV), blood oxygen saturation (SpO2), respiration rate, skin temperature variability, period and ovulation tracking, menstrual symptom tracking, activity profile, including steps, active minutes and calories burned, sleep stages and duration, and mood tracking.

Share on Social Networks: